SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001104659-23-118087 from OCULAR THERAPEUTIX, INC (OCUL) (CIK 0001393434) (OCUL)

OCULAR THERAPEUTIX, INC (OCUL) (CIK 0001393434)
Date: Nov. 14, 2023 · CIK: 0001393434 · Accession: 0001104659-23-118087

AI Filing Summary & Sentiment

File numbers found in text: 333-275373

Date
November 14, 2023
Author
Not clearly detected
Form
CORRESP
Company
OCULAR THERAPEUTIX, INC (OCUL) (CIK 0001393434)

Letter

Ocular Therapeutix, Inc.

24 Crosby Drive

Bedford, MA 01730

November 14, 2023

Via EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re: Ocular Therapeutix, Inc.

Registration Statement on Form S-3

File No. 333-275373

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Ocular Therapeutix, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-275373), so that it may become effective at 4:30 p.m. Eastern time on November 16, 2023, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the Staff.

Very truly yours,
Ocular Therapeutix, Inc.

Show Raw Text
CORRESP
1
filename1.htm

Ocular
Therapeutix, Inc.

24 Crosby Drive

Bedford, MA 01730

November 14, 2023

Via EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

    Re:
    Ocular Therapeutix, Inc.

    Registration Statement on Form S-3

    File No. 333-275373

    Request for Acceleration

Ladies and Gentlemen:

Pursuant
to Rule 461 promulgated under the Securities Act of 1933, as amended, Ocular Therapeutix, Inc. (the “Registrant”)
hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-275373),
so that it may become effective at 4:30 p.m. Eastern time on November 16, 2023, or as soon thereafter as practicable,
or at such later time as the Registrant or its counsel may orally request via telephone call to the Staff.

    Very truly yours,

    Ocular Therapeutix, Inc.

    By:
    /s/ Donald Notman

    Name:
     Donald Notman

    Title:
    Chief Financial Officer

    cc:
    Stuart M. Falber,
    Wilmer Cutler Pickering Hale and Dorr LLP

    C. S. Avery Reaves,
    Wilmer Cutler Pickering Hale and Dorr LLP